This result is probably due to a host of obstacles that are encountered in the tumour microenvironment (TME) of solid tumours14–16, including intrinsic inhibitory pathways mediated by upregulated inhibitory receptors (IRs) responding to their cognate ligands within the tumour, such as in PD1 signalling17. The gene discussed is PDCD1; the disease is neoplasm.